Jazz Pharma Announces $5 billion revenue target for 2025

 Confirms 2021 revenue expected to be within previously announced guidance range, exceeding $3 billion

Company to present at 40th Annual J.P. Morgan Healthcare Conference today, January 10, 2022, at 2:15 - 2:55 p.m. ET / 7:15 - 7:55 p.m. GMT

Presentation and Webcast
Bruce Cozadd will provide a corporate overview and discuss the Company's Vision 2025 during the virtual presentation at the 40th Annual J.P. Morgan Healthcare Conference from 2:15 – 2:55 p.m. ET / 7:15 – 7:55 p.m. GMT on Monday, January 10, 2022.

A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharma.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be available on the website for 30 days.

https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-vision-2025-123000381.html